Author

Guido Alberto Massimo Tiberio

ORCID 0000-0002-7635-1179Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alessia InglesiiD· 1 shared Alfredo BerrutiiD· 1 shared Andrea AbateiD· 1 shared Claudia Bonera· 1 shared Deborah CosentiniiD· 1 shared Domenico CossedduiD· 1 shared Duilio BrugnoniiD· 1 shared Maria ScatoliniiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Alessia InglesiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Updating ACC preclinical models: characterization of two new patient-derived cell lines

Andrea Abate, Mariangela Tamburello, Claudia Bonera, Guido Alberto Massimo Tiberio, Sara Baldelli, Mattia Carini, Alessia Inglesi, Maria Scatolini, Deborah Cosentini, Marta Laganà, Marta Leporati, Pietro Luigi Poliani, Domenico Cosseddu, Duilio Brugnoni, Alfredo Berruti, Sandra Sigala

This paper describes the development and characterization of two new patient-derived ACC cell lines, SMAC-2 and SMAC-3, highlighting their molecular and functional features for preclinical research.

Endocrine Related Cancer · May 1, 2026Peer-reviewedPharmacology & Toxicology